Studies Evaluating Effectiveness of Risk Minimisation Measures

被引：0
|
作者：
Francisca, R. D. C. [1 ]
Zomerdijk, I. M. [1 ]
Sturkenboom, M. C. J. M. [1 ]
Straus, S. M. J. M. [1 ]
机构：
[1] Erasmus MC, Med Informat, Rotterdam, Netherlands
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
713
引用
收藏
页码：416 / 416
页数：1
相关论文
共 50 条
  • [41] The Safety Concerns of Medicinal Products with Additional Risk Minimisation Measures
    Francisca, Remy D. C.
    Leyba, Armando R.
    Zomerdijk, Inge M.
    Sturkenboom, Miriam C. J. M.
    Straus, Sabine M. J. M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 320 - 320
  • [42] Methods to Evaluate Additional Risk Minimisation Measures: A Systematic Review
    Zomerdijk, Inge M.
    Mentink, Kelly
    Gispen-de Wied, Christine C.
    Sturkenboom, Miriam C. J. M.
    Straus, Sabine M. J. M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 261 - 261
  • [43] Evaluating the effectiveness of road mitigation measures
    Edgar A. van der Grift
    Rodney van der Ree
    Lenore Fahrig
    Scott Findlay
    Jeff Houlahan
    Jochen A. G. Jaeger
    Nina Klar
    L. Francisco Madriñan
    Leif Olson
    Biodiversity and Conservation, 2013, 22 : 425 - 448
  • [44] Evaluating the effectiveness of road mitigation measures
    van der Grift, Edgar A.
    van der Ree, Rodney
    Fahrig, Lenore
    Findlay, Scott
    Houlahan, Jeff
    Jaeger, Jochen A. G.
    Klar, Nina
    Madrinan, L. Francisco
    Olson, Leif
    BIODIVERSITY AND CONSERVATION, 2013, 22 (02) : 425 - 448
  • [45] Risk minimisation studies outcomes and process indicators
    Artime, Esther
    Qizilbash, Nawab
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 221 - 221
  • [46] PROBLEMS OF EVALUATING THE EFFECTIVENESS OF DEVELOPMENT MEASURES
    Blaisdell, Thomas C., Jr.
    ECONOMIC DEVELOPMENT AND CULTURAL CHANGE, 1953, 2 : 286 - 296
  • [47] Additional Risk Minimisation Measures for Medicinal Products in the European Union: A Review of the Implementation and Effectiveness of Measures in the United Kingdom by One Marketing Authorisation Holder
    Agyemang E.
    Bailey L.
    Talbot J.
    Pharmaceutical Medicine, 2017, 31 (2) : 101 - 112
  • [48] A web-based survey of UK pharmacists to assess the effectiveness of Viagra Connect(R) additional risk minimisation measures
    Lem, Joanna
    Collins, Janine
    Maguire, Terry
    Sobel, Rachel E.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (03) : 608 - 618
  • [49] Duration of Effectiveness Evaluation of Additional Risk Minimisation Measures for Centrally Authorised Medicinal Products in the EU Between 2012 and 2021
    Essink, Sharon
    Zomerdijk, Inge
    Straus, Sabine
    Gardarsdottir, Helga
    De Bruin, Marie
    DRUG SAFETY, 2023, 46 (10) : 1007 - 1020
  • [50] Effectiveness Evaluation of the Additional Risk Minimisation Measures for Yellow Fever Vaccine in the United Kingdom: A Survey for Healthcare Professionals and Vaccinees
    Li, Lin
    Karimi, Leila
    Luguzis, Artis
    Pawar, Neha
    Guichard, Marie-Caroline
    Thollot, Yael
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 496 - 496
12345